Schonfeld Strategic Advisors LLC Clear Point Neuro, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 46,388 shares of CLPT stock, worth $488,929. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,388
Previous 106,172
56.31%
Holding current value
$488,929
Previous $1.63 Million
66.24%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CLPT
# of Institutions
110Shares Held
8.79MCall Options Held
243KPut Options Held
30.2K-
Vanguard Group Inc Valley Forge, PA1.48MShares$15.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny741KShares$7.81 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA625KShares$6.59 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA482KShares$5.08 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$3.86 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $258M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...